DYN NASDAQ
Dyne Therapeutics, Inc.
1W: +9.3%
1M: +24.4%
3M: +40.4%
YTD: +38.5%
1Y: +177.4%
3Y: +133.2%
5Y: +30.2%
$25.90
+0.27 (+1.05%)
After Hours: $26.60 (+0.70, +2.70%)
Weekly Expected Move ±6.4%
$21
$23
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.3M
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.2B
52W Range8.88-26.12
Volume3,201,008
Avg Volume2,056,675
Beta1.06
Dividend—
Analyst Ratings
Company Info
CEOJohn G. Cox
Employees263
SectorHealthcare
IndustryBiotechnology
IPO Date2020-09-17
Websitedyne-tx.com
1560 Trapelo Road
Waltham, MA 02451
US
Waltham, MA 02451
US
781 786 8230
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Latest News
Fifth Third Bancorp Buys New Shares in Dyne Therapeutics, Inc. $DYN
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
Biggest stock movers Wednesday: SMCI, DYN, OKLO, and more
Dyne Therapeutics stock slips after pricing upsized $375M public offering at $20.50 per share
DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rhodes Jason P | S-Sale | 124,379 | $23.17 | 2026-07-07 |
| Rhodes Jason P | S-Sale | 29,587 | $23.62 | 2026-07-07 |
| Rhodes Jason P | S-Sale | 62,543 | $23.17 | 2026-07-07 |
| Rhodes Jason P | S-Sale | 14,844 | $23.62 | 2026-07-07 |
| Rhodes Jason P | S-Sale | 49,193 | $23.17 | 2026-07-07 |